cytosine has been researched along with Experimental Lung Inflammation in 12 studies
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A patient with Aspergillus pneumonia was treated with a synergistic combination of amphotericin B and flucytosine." | 7.66 | Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia. ( Codish, SD; Hannigan, M; Tobias, JS, 1979) |
| " A patient with Aspergillus pneumonia was treated with a synergistic combination of amphotericin B and flucytosine." | 3.66 | Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia. ( Codish, SD; Hannigan, M; Tobias, JS, 1979) |
| " To confirm the safety and tolerability of dosing schedules, after 20 patients had been treated in a group we enrolled an expanded cohort of 20-25 patients to that group if at least four patients had achieved complete remission or complete remission with incomplete blood count recovery, and if the 30 day death rate was 20% or less." | 2.77 | Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. ( Arellano, M; Chiao, J; Claxton, D; Coutre, S; Faderl, S; Garcia-Manero, G; Goldberg, SL; Jabbour, E; Kantarjian, H; Luger, S; Maness, L; Plunkett, W; Schiller, G; Seiter, K; Stock, W; Strickland, SA; Venugopal, P; Wetzler, M, 2012) |
| "All patients had progressive respiratory failure with lobar consolidation with or without patchy ground glass opacity." | 1.42 | Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia. ( Hong, DJ; Jhun, BW; Kim, K; Kim, SJ; Park, SB, 2015) |
| "The efficacy of cidofovir for treatment of cowpox virus infection in BALB/c mice was investigated in an effort to evaluate new therapies for virulent orthopoxvirus infections of the respiratory tract in a small animal model." | 1.31 | Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. ( Bray, M; Huggins, JW; Kefauver, D; Martinez, M; Smee, DF; Thompson, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoki, K | 1 |
| Jaruga, P | 1 |
| Itazawa, T | 1 |
| Aguilera-Aguirre, L | 1 |
| Coskun, E | 1 |
| Hazra, TK | 1 |
| Boldogh, I | 1 |
| Dizdaroglu, M | 1 |
| Sur, S | 1 |
| Kim, SJ | 1 |
| Kim, K | 1 |
| Park, SB | 1 |
| Hong, DJ | 1 |
| Jhun, BW | 1 |
| Lilleri, D | 1 |
| Gerna, G | 1 |
| Rivière, F | 1 |
| Gille, T | 1 |
| Le Tinier, JY | 1 |
| Gharbi, N | 1 |
| Khalil, A | 1 |
| Wislez, M | 1 |
| Cadranel, J | 1 |
| Kantarjian, H | 1 |
| Faderl, S | 1 |
| Garcia-Manero, G | 1 |
| Luger, S | 1 |
| Venugopal, P | 1 |
| Maness, L | 1 |
| Wetzler, M | 1 |
| Coutre, S | 1 |
| Stock, W | 1 |
| Claxton, D | 1 |
| Goldberg, SL | 1 |
| Arellano, M | 1 |
| Strickland, SA | 1 |
| Seiter, K | 1 |
| Schiller, G | 1 |
| Jabbour, E | 1 |
| Chiao, J | 1 |
| Plunkett, W | 1 |
| Yassin, AF | 1 |
| Rainey, FA | 1 |
| Brzezinka, H | 1 |
| Burghardt, J | 1 |
| Rifai, M | 1 |
| Seifert, P | 1 |
| Feldmann, K | 1 |
| Schaal, KP | 1 |
| Drew, WL | 1 |
| Lalezari, JP | 1 |
| Bray, M | 1 |
| Martinez, M | 1 |
| Smee, DF | 1 |
| Kefauver, D | 1 |
| Thompson, E | 1 |
| Huggins, JW | 1 |
| Torres, G | 1 |
| Codish, SD | 1 |
| Tobias, JS | 1 |
| Hannigan, M | 1 |
| Dowell, AR | 1 |
| Stibbins, DE | 1 |
| Jay, AC | 1 |
| List, J | 1 |
| Brennan, PC | 1 |
| Fritz, TE | 1 |
| Flynn, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase 2 Study of Oral Sapacitabine in Elderly Patients With Acute Myeloid Leukemia Previously Untreated or in First Relapse, or Previously Treated Myelodysplastic Syndromes[NCT00590187] | Phase 2 | 408 participants (Actual) | Interventional | 2007-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cytosine and Experimental Lung Inflammation
| Article | Year |
|---|---|
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.
Topics: Acetates; Adult; Animals; Antiviral Agents; Asymptomatic Diseases; Benzimidazoles; Clinical Trials a | 2016 |
Cytomegalovirus: disease syndromes and treatment.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioreti | 1999 |
2 trials available for cytosine and Experimental Lung Inflammation
| Article | Year |
|---|---|
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Arabinonucleosides; Cytosine; Disease-Free Su | 2012 |
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocy | 1995 |
8 other studies available for cytosine and Experimental Lung Inflammation
| Article | Year |
|---|---|
Excision release of 5?hydroxycytosine oxidatively induced DNA base lesions from the lung genome by cat dander extract challenge stimulates allergic airway inflammation.
Topics: Allergens; Animals; Biomarkers; Cats; Chromatography, Gas; Cytosine; Disease Models, Animal; DNA Dam | 2018 |
Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Cidofovir; Cytosine; Drug-Related Side Effects an | 2015 |
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Or | 2011 |
Tsukamurella pulmonis sp. nov.
Topics: Aged; Aged, 80 and over; Bacterial Proteins; Base Sequence; Cytosine; DNA, Bacterial; Female; Guanin | 1996 |
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Bronchi; Cidofovir; Cowpox; Cytosin | 2000 |
Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Cytosine; Drug Synergism; Drug Therapy, Combin | 1979 |
Therapeutic failure of 5-fluorocytosine in a patient with cryptococcal meningitis and pneumonia.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cytosine; Humans; Male; Meningitis; Midd | 1973 |
Role of Pasteurella pneumotropica and Mycoplasma pulmonis in murine pneumonia.
Topics: Animals; Cytosine; DNA; Fluorescent Antibody Technique; Germ-Free Life; Guanine; Hot Temperature; L | 1969 |